Kenneth Hoberman
Board Member
Nuvectis Pharma, Inc. (NVCT)Board Member
Tg Therapeutics, Inc. (TGTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth Hoberman
Kenneth Hoberman is recorded as Board Member at Nuvectis Pharma, Inc. (NVCT) and Board Member at Tg Therapeutics, Inc. (TGTX). Tg Therapeutics, Inc. reported in an 8-K filed June 17, 2024 that Kenneth Hoberman was appointed Director, effective June 14, 2024.
“The votes with respect to the election of the six directors to hold office until the 2025 annual meeting were as follows: Kenneth Hoberman 52,058,723 68.40% 24,055,703 31.60% 34,960,603”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
-
Current
2014-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Nuvectis Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Ron Bentsur CEO, Board Member
- James Oliviero Board Member
- Juan Sanchez Board Member
- Juan Sanchez, MD Board Member
- Matthew Kaplan Board Member
Leadership on record at Tg Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael S. Weiss CEO, Board Member
- Sean A. Power CFO
- Daniel Hume Board Member
- Dr. Sagar Lonial Board Member
- Laurence Charney Board Member
- Laurence N. Charney Board Member
- Sagar Lonial Board Member
- Sagar Lonial, MD Board Member
- Yann Echelard Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.